Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Susceptibility testing for mycobacteria.

G L Woods1

  • 1University of Texas Medical Branch, Galveston, TX 77555-0740, USA. gwoods@utmb.edu

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|November 14, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efforts of the United States' National Marrow Donor Program and Registry to improve utilization and representation of minority donors.

Transfusion medicine (Oxford, England)·2008
Same author

Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2006
Same author

Antimicrobial susceptibility patterns in Pseudomonas aeruginosa: data from a multicenter Intensive Care Unit Surveillance Study (ISS) in the United States.

Journal of chemotherapy (Florence, Italy)·2004
Same author

Management of complicated appendicitis and comparison of outcome with other primary sites of intra-abdominal infection: results of a trial comparing ertapenem and piperacillin-tazobactam.

Journal of chemotherapy (Florence, Italy)·2004
Same author

A rapid immunochromatographic assay for hepatitis B virus screening.

Journal of viral hepatitis·2003
Same author

Expression of the uterine Mx protein in cyclic and pregnant cows, gilts, and mares.

Journal of animal science·2003
Same journal

The balance between a new Antibiotic and Non-antibiotic Alternatives for the treatment and prevention of uncomplicated Urinary Tract Infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Understanding the Clone-Censor-Weight Method in Observational Studies of Antibiotic Duration.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, Bangladesh.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIV.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Reconsidering ambiguous language in infectious disease consult recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

The National Committee for Clinical Laboratory Standards (NCCLS) updated its guidelines for mycobacterial susceptibility testing. Document M24-T2 provides revised and new recommendations for tuberculosis and nontuberculous mycobacteria testing in clinical labs.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Accurate mycobacterial susceptibility testing is crucial for managing tuberculosis and nontuberculous mycobacterial infections.
  • Standardized laboratory methods are essential for reliable susceptibility testing.
  • The National Committee for Clinical Laboratory Standards (NCCLS) previously issued document M24-T in 1995.

Purpose of the Study:

  • To review the updated NCCLS document M24-T2, which provides tentative standards for antimycobacterial susceptibility testing.
  • To highlight the revisions and new guidelines for testing various mycobacterial species and related organisms.
  • To inform clinical microbiology laboratories about the latest recommendations for mycobacterial susceptibility testing.

Main Methods:

Related Experiment Videos

  • Review of the NCCLS document M24-T2, the second edition of the tentative standard for antimycobacterial susceptibility testing.
  • Analysis of revised guidelines for Mycobacterium tuberculosis complex testing.
  • Examination of newly proposed guidelines for nontuberculous mycobacteria, including rapidly growing mycobacteria, Mycobacterium avium complex, Mycobacterium kansasii, Mycobacterium marinum, and Nocardia species.

Main Results:

  • The updated NCCLS document M24-T2 presents significant revisions from the 1995 version.
  • It includes revised guidelines for Mycobacterium tuberculosis complex susceptibility testing.
  • New guidelines are proposed for a broader range of nontuberculous mycobacteria and aerobic actinomycetes.

Conclusions:

  • NCCLS document M24-T2 offers updated and expanded recommendations for mycobacterial susceptibility testing.
  • These guidelines aim to standardize testing methods in clinical microbiology laboratories.
  • The document is essential for clinicians and laboratorians managing mycobacterial infections.